Protalix BioTherapeutics (PLX) Debt to Equity (2011 - 2024)
Protalix BioTherapeutics' quarterly Debt to Equity came in at $0.71 in Q2 2024, up 4.22% quarter-over-quarter from $0.69 in Q1 2024.
Protalix BioTherapeutics has reported Debt to Equity for 11 years, with the latest figure at $0.71 in Q2 2024.
- For the quarter ending Q2 2024, Debt to Equity changed N/A year-over-year to $0.71; the trailing twelve-month figure through Jun 2024 stood at $0.71 (changed N/A YoY), and the FY2023 full-year result was $0.6, changed N/A from the prior year.
- Debt to Equity for Q2 2024 stood at $0.71, up from $0.69 in the prior quarter.
- The five-year high for Debt to Equity was $15.21 in Q3 2021, with the low at -$2.01 in Q4 2020.
- Average Debt to Equity over 4 years is $4.28, with a median of $0.7 recorded in 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.06 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 0.71 |
| Mar 31, 2024 | 0.69 |
| Dec 31, 2023 | 0.60 |
| Sep 30, 2023 | 0.53 |
| Sep 30, 2021 | 15.21 |
| Jun 30, 2021 | 14.67 |
| Mar 31, 2021 | 3.82 |
| Dec 31, 2020 | -2.01 |
| Mar 31, 2018 | -0.17 |
| Dec 31, 2017 | -0.20 |
| Sep 30, 2017 | -0.39 |
| Jun 30, 2017 | -0.21 |
| Mar 31, 2017 | -0.06 |
| Dec 31, 2016 | -5.84 |
| Sep 30, 2016 | -0.28 |
| Jun 30, 2016 | -0.54 |
| Mar 31, 2016 | 1.62 |
| Dec 31, 2015 | 0.40 |
| Dec 31, 2013 | -0.09 |
| Jun 30, 2013 | -0.03 |
| Mar 31, 2013 | -0.43 |
| Dec 31, 2012 | -1.62 |
| Sep 30, 2012 | 0.59 |
| Jun 30, 2012 | 0.60 |
| Dec 31, 2011 | -0.25 |
| Sep 30, 2011 | -0.27 |
| Jun 30, 2011 | -0.51 |